Patents Assigned to CLARUS CLS HOLDINGS, LLC
  • Patent number: 10849928
    Abstract: A topical ophthalmic composition comprised of povidone-iodine 0.01% to 10.0% combined with a steroid or non-steroidal anti-inflammatory drug. This solution is useful in the treatment of active infections of at least one tissue of the eye (e.g., conjunctiva and cornea) from bacterial, mycobacterial, viral, fungal, or amoebic causes, as well as treatment to prevent such infections in appropriate clinical settings (e.g. corneal abrasion, postoperative prophylaxis, post-LASIK/LASEK prophylaxis). Additionally the solution is effective in the prevention of infection and inflammation in the post-operative ophthalmic patient.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: December 1, 2020
    Assignee: Clarus CLS Holdings, LLC
    Inventors: C. Michael Samson, Bo Liang, Joseph A. Capriotti
  • Publication number: 20180303869
    Abstract: A topical ophthalmic composition comprised of povidone-iodine 0.01% to 10.0% combined with a steroid or non-steroidal anti-inflammatory drug. This solution is useful in the treatment of active infections of at least one tissue of the eye (e.g., conjunctiva and cornea) from bacterial, mycobacterial, viral, fungal, or amoebic causes, as well as treatment to prevent such infections in appropriate clinical settings (e.g. corneal abrasion, postoperative prophylaxis, post-LASIK/LASEK prophylaxis). Additionally the solution is effective in the prevention of infection and inflammation in the post-operative ophthalmic patient.
    Type: Application
    Filed: November 28, 2017
    Publication date: October 25, 2018
    Applicant: Clarus CLS Holdings, LLC
    Inventors: C. Michael SAMSON, Bo LIANG, Joseph A. CAPRIOTTI
  • Patent number: 9855295
    Abstract: A topical ophthalmic composition comprised of povidone-iodine 0.01% to 10.0% combined with a steroid or non-steroidal anti-inflammatory drug. This solution is useful in the treatment of active infections of at least one tissue of the eye (e.g., conjunctiva and cornea) from bacterial, mycobacterial, viral, fungal, or amoebic causes, as well as treatment to prevent such infections in appropriate clinical settings (e.g. corneal abrasion, postoperative prophylaxis, post-LASIK/LASEK prophylaxis). Additionally the solution is effective in the prevention of infection and inflammation in the post-operative ophthalmic patient.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: January 2, 2018
    Assignee: CLARUS CLS HOLDINGS, LLC
    Inventors: C. Michael Samson, Bo Liang, Joseph A. Capriotti